RxDoctor Payments Data

Thomas Mathews, MD

Cardiology · Brooksville, FLNPI 1316926421

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,078 of the $4,184 with a category attached, or 73.6%. 12 manufacturers reported payments, led by Angiodynamics, Inc. at 27.0% of the total.

$4,184in general payments, 2019–2025

Across 70 payments — averaging $59.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$1K
  • Stryker$769
  • Inari Medical, Inc.$661
  • Abbott$490
  • Medtronic$321
  • Terumo Medical Corporation$305
  • plus $507 from 6 others

What the payments were for

  • Speaking & faculty fees$1063%
  • Travel & lodging$1,00024%
  • Food & beverage$3,07874%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,184 in reported general payments places this provider in the 75th percentile of 45 cardiology providers in Florida.

See all cardiology providers in Florida

Medicare billing

Part B allowed, 2024
$1,682,050
Medicare patients
1,365
Services billed
20,745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban313$322,507
MultaqDronedarone Hcl65$85,679
Ranolazine ErRanolazine675$80,126
EntrestoSacubitril/Valsartan39$38,828
BrilintaTicagrelor54$35,565
XareltoRivaroxaban37$33,888
FarxigaDapagliflozin Propanediol33$25,698
Nebivolol Hcl259$21,357
Dabigatran EtexilateDabigatran Etexilate Mesylate65$21,216
Carvedilol1,443$11,971
ClopidogrelClopidogrel Bisulfate850$9,765
Isosorbide Mononitrate ErIsosorbide Mononitrate605$8,434
Nitroglycerin586$7,378
Amiodarone Hcl166$7,151
Midodrine Hcl90$5,737

Paid to pharmacies, not to this prescriber.

Other cardiology in Brooksville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →